COVID-19 AP TP Vaccine
COVID-19 AP TP Vaccine Uses, Dosage, Side Effects, Food Interaction and all others data.
As of July 2020, Medicine Invention Design, Inc. is sponsoring a small, controlled clinical trial for the COVID-19 AP TP Vaccine for ‘proof of concept.’ The vaccine utilizes granulocyte macrophage-colony stimulating factor (GM-CSF), a cytokine known to enhance vaccine efficacy through prolongation of humoral and cell immunity.
Trade Name | COVID-19 AP TP Vaccine |
Generic | COVID-19 Nucleocapsid-GM-CSF Protein Lactated Ringer's Injection |
COVID-19 Nucleocapsid-GM-CSF Protein Lactated Ringer's Injection Other Names | AP-TP-V, COVID-19 AP TP Vaccine, COVID-19 Therapeutic Vaccine - Nucleocapsid-GM-CSF Protein Lactated Ringer's Injection |
Type | |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here COVID-19 AP TP Vaccine